Breaking News Instant updates and real-time market news.

CME

CME Group

$173.53

-2.53 (-1.44%)

13:57
10/12/18
10/12
13:57
10/12/18
13:57

CME Group receives DOJ clearance for proposed NEX acquisition

CME Group announced that it has received clearance under the Hart-Scott-Rodino Act from the United States Department of Justice - Antitrust Division for its proposed acquisition of NEX Group. CME and NEX have also received the relevant regulatory approvals from the FCA and regulators in the United States, Germany, Italy and Sweden, and have made the requisite pre-notifications in Hong Kong. Completion of the transaction remains subject to satisfaction or waiver of the remaining closing conditions, including competition clearance from the UK Competition and Markets Authority and the sanctioning of the transaction by the U.K. Court. The parties still expect the closing to occur by year end 2018.

  • 05

    Nov

CME CME Group
$173.53

-2.53 (-1.44%)

07/10/18
07/10/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Spotify (SPOT) initiated with a Perform at Oppenheimer. 2. CME Group (CME) initiated with a Neutral at Compass Point. 3. Weight Watchers (WTW) initiated with an Overweight at KeyBanc. 4. Fossil (FOSL) initiated with an Overweight at KeyBanc. 5. Alvarion (ALVR) initiated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/05/18
RSBL
09/05/18
INITIATION
Target $177
RSBL
Neutral
CME Group initiated with a Neutral at Rosenblatt
Rosenblatt analyst Ken Hill initiated CME Group with a Neutral and $177 price target saying expectations for higher volumes are reflected in valuation.
09/07/18
WELS
09/07/18
NO CHANGE
Target $115
WELS
Outperform
Cboe risk/reward attractive heading into fall, says Wells Fargo
Wells Fargo analyst Christopher Harris believes the VIX complex volumes bottomed in August, creating and attractive risk/reward for shares of Cboe Global Markets (CBOE) heading into the fall. Supporting data include steadily rising open interest trends, recent improvement in volume trends and better VIX exchange-traded product flows, Harris tells investors in a research note. In addition, Cboe's relative valuation versus CME Group (CME) "has rarely been this low," the analyst adds. He keeps an Outperform rating on Cboe Global Markets with a $115 price target.
10/08/18
JEFF
10/08/18
NO CHANGE
Target $203
JEFF
Buy
CME Group price target raised to $203 from $190 at Jefferies
Jefferies analyst Daniel Fannon raised his price target for CME Group to $203 and keeps a Buy rating on the shares after spending time with management. While September volumes came in slightly below expectations, open interest figures continue to grow and the macro backdrop remains conducive to higher volatility, Fannon tells investors in a research note. further, he believes the NEX transaction appears to be on track to close before year end and should provide both earnings accretion and additional revenue growth opportunities. The analyst keeps a Buy rating on CME Group.

TODAY'S FREE FLY STORIES

OGE

OGE Energy

$41.94

0.01 (0.02%)

07:13
02/21/19
02/21
07:13
02/21/19
07:13
Earnings
Breaking Earnings news story on OGE Energy »

OGE Energy sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

AERI

Aerie Pharmaceuticals

$39.56

-1.25 (-3.06%)

07:13
02/21/19
02/21
07:13
02/21/19
07:13
Recommendations
Aerie Pharmaceuticals analyst commentary  »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 14

    Mar

  • 18

    Mar

OGE

OGE Energy

$41.94

0.01 (0.02%)

07:12
02/21/19
02/21
07:12
02/21/19
07:12
Earnings
OGE Energy reports Q4 EPS 27c, consensus 23c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BRC

Brady

$47.35

0.59 (1.26%)

07:12
02/21/19
02/21
07:12
02/21/19
07:12
Earnings
Brady raises FY19 EPS view to $2.25-$2.35 from $2.20-$2.30, consensus $2.28 »

Backs FY19 organic sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

VRCA

Verrica Pharmaceuticals

$10.99

-0.12 (-1.08%)

07:11
02/21/19
02/21
07:11
02/21/19
07:11
Initiation
Verrica Pharmaceuticals initiated  »

Verrica Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

ARRS

Arris

$31.65

0.025 (0.08%)

07:11
02/21/19
02/21
07:11
02/21/19
07:11
Earnings
Arris reports preliminary Q4 adjusted EPS 76c, consensus 75c »

Reports Q4 preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Hot Stocks
Wendy's approves new $225M share repurchase program »

At the end of 2018, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

QEP

QEP Resources

$8.19

-0.08 (-0.97%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Recommendations
QEP Resources analyst commentary  »

Elliott may push for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BRC

Brady

$47.35

0.59 (1.26%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Earnings
Brady reports Q2 EPS 55c, consensus 52c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

AVB

AvalonBay

$194.14

-2.37 (-1.21%)

07:09
02/21/19
02/21
07:09
02/21/19
07:09
Downgrade
AvalonBay rating change  »

Citi downgrades AvalonBay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:09
02/21/19
02/21
07:09
02/21/19
07:09
Hot Stocks
Breaking Hot Stocks news story on Ardagh Group »

Ardagh Group sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Ardagh Group sees FY19 adjusted EPS $1.60-$1.75, consensus $1.76 »

2019 outlook: Full year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IRT

Independence Realty Trust

$10.71

-0.01 (-0.09%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Independence Realty sees FY19 EPS 76c-80c, may not compare to consensus 24c 

Sees FY19 CFFO 74c-78c.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Wendy's sees FY20 global systemwide sales of approximately $11.5B »

Sees FY20 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

ALB

Albemarle

$82.82

-0.305 (-0.37%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Recommendations
Albemarle analyst commentary  »

Oppenheimer says remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 27

    Feb

  • 27

    Feb

BDC

Belden

$63.83

7.19 (12.69%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Recommendations
Belden analyst commentary  »

Belden price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    May

  • 14

    May

  • 15

    May

MCRN

Milacron

$14.78

0.13 (0.89%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Milacron sees FY19 pro forma sales growth 0%-1%, consensus $1.28B »

In line with current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Ardagh Group reports Q4 adjusted EPS 33c, consensus 28c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GIL

Gildan Activewear

$34.17

-0.17 (-0.50%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Breaking Earnings news story on Gildan Activewear »

Gildan Activewear sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IRT

Independence Realty Trust

$10.71

-0.01 (-0.09%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Independence Realty Trust reports Q4 EPS 16c, consensus 5c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Wendy's sees FY19 adjusted EPS growth of 3.5%-7%, consensus 66c »

Sees FY19 global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

BTX

BioTime

$1.16

-0.11 (-8.66%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Initiation
BioTime initiated  »

BioTime initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 07

    Mar

GIL

Gildan Activewear

$34.17

-0.17 (-0.50%)

07:06
02/21/19
02/21
07:06
02/21/19
07:06
Earnings
Breaking Earnings news story on Gildan Activewear »

Gildan Activewear sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

FARO

Faro Technologies

$43.78

-4.16 (-8.68%)

07:06
02/21/19
02/21
07:06
02/21/19
07:06
Downgrade
Faro Technologies rating change  »

Faro Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCOI

Cogent

$49.78

-0.495 (-0.98%)

07:06
02/21/19
02/21
07:06
02/21/19
07:06
Hot Stocks
Cogent raises quarterly dividend to 58c from 56c per share »

Payable on March 29 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 11

    Mar

  • 11

    Mar

  • 13

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.